When war breaks out, the market usually runs to the usual suspects first.

Missile makers. Drone companies. Radar systems. Ammunition manufacturers. The old-line defense contractors that everybody can recognize without even opening a 10-K.

And to be fair, that trade makes sense… 

As the conflict with Iran escalated this month, investors quickly recognized that military spending, replenishment orders, and national-security urgency would be a gift to the traditional defense complex. 

And at the same time, broader markets wobbled under the pressure of oil shocks, inflation fears, and geopolitical uncertainty. 

But while the market was staring at tanks, drones, and interceptors, another battlefield was expanding right under its nose.

The Obvious Winners Aren’t the Only Winners

That battlefield was digital.

Reuters reported in early March that U.S. banks had already gone on heightened alert for potential Iran-linked cyberattacks as the war escalated, with industry groups and executives emphasizing operational resilience across critical financial infrastructure. 

Intelligence assessments cited by Reuters said Iran-aligned hacktivists could launch low-level cyberattacks against U.S. networks, and advisers flagged Iran’s willingness to target commercial systems, including financial ones. 

That tells us this is not a niche side story. It’s not just a Pentagon issue. It’s not just a “government IT” issue. To be fair, it’s not even just a banking issue.

It’s an everything issue…

War No Longer Stays on the Battlefield

One of the great mistakes investors keep making is imagining war in twentieth-century terms while living in a twenty-first-century world.

They still think war is mostly about ships, planes, bombs, and boots. And those things still matter, of course. 

But modern conflict spills into payment systems, hospital networks, supply chains, cloud architecture, executive communications, industrial controls, and surveillance networks. 

In other words, it spills into the plumbing of modern life.

The Justice Department announced on March 19 that it had seized four domains tied to Iran’s Ministry of Intelligence and Security..

Those sites were used to support hacking efforts, psychological operations, stolen-data publication, and even calls for the killing of journalists and dissidents. 

That’s not just cybercrime. That is cyberwar blended with intimidation, propaganda, and transnational pressure. 

And the public-sector warnings have been piling up, too… 

CISA’s Iran threat advisory says U.S. critical infrastructure and other U.S. entities should remain vigilant for targeted cyber activity by Iranian-affiliated actors.

And FINRA has warned firms about heightened threats from Iranian cyber actors amid the current Middle East tensions. 

This is what markets periodically forget: when the geopolitical temperature rises, hackers don’t need aircraft carriers to make themselves felt. 

They need access, automation, patience, and a vulnerable target. And that target can be a federal agency or military base. 

But it can also be a hospital, a manufacturer, a bank, a logistics company, an energy operator, or a wealthy executive with information that looks interesting to the wrong people.

AI Didn’t Eliminate Cyber Risk. It Supercharged It

Now let’s talk about the part that makes last month’s cybersecurity selloff look so silly.

In late February, shares of cybersecurity companies including CrowdStrike, Datadog, and Zscaler fell around 11% in a single session after Anthropic launched a coding-security tool.

Fortinet, Okta, Palo Alto Networks, and SentinelOne also all plunged as investors worried AI tools would pressure the industry. 

The market was acting as though AI might flatten the moat around cybersecurity vendors and somehow automate away the need for them. 

That was always a shallow read.

AI doesn’t magically make vulnerabilities disappear. It accelerates both sides of the contest. 

Yes, it helps defenders move faster, but it also helps attackers scan, probe, craft lures, exploit weaknesses, and sift through stolen data at machine speed.

Zscaler’s 2026 AI Threat Report says enterprise AI systems could often be compromised in as little as 16 minutes, found critical flaws in 100% of systems analyzed, and reported that data transfers to AI and machine-learning applications surged 93% to more than 18,000 terabytes. 

In plain English, AI is expanding the attack surface even as it becomes part of the defense stack. 

Palo Alto Networks put it even more bluntly in its 2026 outlook, arguing that 2026 would be the “Year of the Defender,” with AI-driven defenses needed to counter attackers who are using AI to scale and accelerate threats. 

That’s the real story. AI is not replacing cybersecurity. 

AI is making cybersecurity more necessary, more complex, and more central to national and corporate survival.

The Camera Is Now a Weapon

If investors needed a more vivid example, they got one…

Associated Press reported this week that hacked surveillance systems played a role in Israel’s targeting of Iran’s leadership, with advances in AI allowing intelligence services to sift through huge amounts of camera footage and identify targets far faster than human teams could. 

The AP report also noted that experts have long warned that internet-connected cameras could be hacked and weaponized, and that AI now makes automated target identification vastly more feasible in real time. 

Pause there for a second.

A camera used to be a passive device. Now it can become an intelligence node. A security feed can become a targeting tool. A convenience product can become a wartime liability.

That is a massive theme, and it stretches far beyond Tehran.

Corporate campuses have cameras. Warehouses have cameras. Energy facilities have cameras. Private homes have cameras. Gated neighborhoods have cameras. 

Transportation hubs have cameras. Governments have cameras everywhere. 

The more connected the world becomes, the more surfaces there are to attack, hijack, spoof, or exploit.

And when AI can process those feeds at scale, the stakes get even higher.

That doesn’t shrink the cybersecurity market. It expands it.

Uncle Sam and Corporate America Need the Same Shield

Another reason the recent selloff looked unreasonable is that the demand base for cybersecurity isn’t narrow. It is broadening.

The federal government is leaning harder into AI-enabled cyber defense. 

Agencies and industry are exploring AI to strengthen cybersecurity as the administration’s cyber strategy places a premium on using AI to better secure federal networks. 

At the same time, government procurement is not theoretical. 

GSA announced a OneGov agreement with Palo Alto Networks covering AI security, cloud security, next-generation firewalls, and zero-trust access for federal infrastructure through January 2028. 

CrowdStrike said in March that it expanded GovCloud capabilities for public-sector agencies inside a FedRAMP High-authorized environment, explicitly positioning those tools to stop AI-accelerated threats. 

Zscaler continues to market zero-trust tools for the Department of Defense, while SentinelOne highlights a FedRAMP-High platform for federal civilian agencies. 

That’s just the public side.

On the private side, reporting on the banking sector shows the same pattern: commercial firms don’t get to opt out of cyber conflict just because they don’t wear uniforms. 

Financial institutions, medical-device companies, and other enterprises are all in the blast radius when geopolitical actors start using digital channels to spread disruption. 

So, when investors think about cybersecurity now, they shouldn’t think of it as just another software bucket competing for budget with marketing tools and workflow apps. 

They should think of it as strategic infrastructure.

That’s an entirely different category. And categories like that tend to command better multiples over time than the market gives them during panic selloffs.

The Selloff Was a Story Problem, Not a Business Problem

Markets love neat stories…

Last month’s story was that AI would commoditize huge chunks of software, compress margins, and expose parts of cybersecurity as less special than investors thought.

Cute story. Bad conclusion.

Because the actual business backdrop moved in the opposite direction.

The Iran conflict increased the urgency around cyber readiness… 

Official warnings intensified. Law-enforcement actions accelerated. Private-sector vigilance rose. AI-related attack surfaces kept growing. 

And the examples coming out of the region showed that digital tools are now deeply embedded in modern conflict, intelligence, and retaliation. 

That doesn’t sound like an industry heading for irrelevance.

It sounds like an industry getting repriced by reality.

And that’s usually where opportunity lives.

Where Investors Should Start Looking

This is not a call to blindly buy every stock with the word “cyber” in its investor presentation. 

Plenty of companies will overpromise. Some will get out-innovated. Some will spend years proving they can turn technological relevance into durable profits.

But the broad theme is getting harder to ignore…

Investors who want to understand this space better should be studying the companies building AI-enabled defense, zero-trust architecture, endpoint security, identity protection, cloud workload defense, and public-sector compliant platforms. 

Names like Palo Alto Networks, CrowdStrike, Zscaler, SentinelOne, Fortinet, Okta, and Check Point all touch pieces of that evolving battlefield, though each does so differently and with different risk-reward profiles. 

February’s selloff shows how sharply sentiment can swing in these names, which is exactly why serious investors should do the work before the crowd rediscovers the thesis. 

The bigger point is simpler than any one ticker.

AI is not a magic wand that fixes cyber risk. It’s gasoline on the fire, but it’s also a better hose for the firefighters at the same time. 

And in a world where states, proxies, criminals, and ideological actors can all use digital tools to reach across borders, cybersecurity is no longer an optional growth category. 

It’s a critical part of the defense stack itself.

That means last month’s selloff may start looking less like insight and more like a gift, even sooner than expected.

Investors who understand that early won’t just be buying software. 

They’ll be buying exposure to the companies turning AI into a shield against the people trying to use it as a sword.

Every few years, Wall Street rediscovers a very old truth: some of the most valuable businesses in the world are built around solving the problems that matter most. 

And it’s hard to find a problem bigger than cancer.

That’s what makes oncology such an interesting hunting ground for investors. 

This isn’t just another trendy corner of biotech where everybody chases a buzzword for six months and moves on. 

The Biggest Market Nobody Can Ignore

Cancer treatment is one of the few areas where real scientific progress can create massive value, not just because the market is huge, but because the need is permanent. 

As researchers get better at identifying specific tumor markers, training the immune system, and delivering drugs more precisely, the range of possible winners keeps expanding. 

That creates a real opportunity for retail investors. 

You don’t need to be a hedge fund biotech specialist with a PhD in molecular biology to see what’s happening here. You just need to understand the basic setup…

The old model of blasting patients with broad, toxic chemotherapy is slowly giving way to more targeted approaches. 

Some of those approaches are already proving themselves commercially. 

Others are earlier and more speculative, but they’re inching closer to clinical moments that could change how the market values them overnight. 

Don’t Look for One Hero

This is where a lot of investors get themselves into trouble… 

They go hunting for one miracle stock, one tiny biotech, one glorious “I found it first” story they can brag about later. 

That sounds great in theory. In practice, it’s usually how people get wiped out by one ugly trial result, one financing round, or one regulatory delay.

The better way to approach this space is to think like a portfolio builder, not a gambler. 

Oncology is not one trade. It’s a collection of different technological bets. 

You’ve got radioligand therapies, antibody-drug conjugates, precision small molecules, immune-cell therapies, and natural killer cell engagers all pushing toward the same prize from different angles. 

The smart move is not to marry one company and pray. 

The smart move is to own a basket of serious contenders across different treatment platforms and let the eventual winners do the heavy lifting. 

That’s how I’d frame this whole opportunity…

Not as a biotech lottery ticket, but as a long-term portfolio theme. A basket of potential cancer cures. 

Some of them are safer. Some are more explosive. Some will fail. That’s part of the game. 

But if you spread your exposure intelligently, you give yourself a shot at capturing upside from one of the most important innovation cycles in the market.

The Grown-Up Money

If you want to start on the safer side, begin with the big, established players that already have real oncology businesses and real resources behind them.

Novartis is one of the clearest examples… 

Its Pluvicto franchise has made radioligand therapy one of the most compelling treatment categories in oncology, and in February 2026 the company released new real-world data reinforcing earlier use of Pluvicto before chemotherapy in metastatic castration-resistant prostate cancer. 

The company said chemo-naïve patients with PSMA-positive disease showed median progression-free survival of 13.5 months. 

That matters because when a treatment starts moving earlier in the line of care, the commercial opportunity tends to get much bigger. 

AstraZeneca belongs in that same “grown-up money” bucket… 

Its exposure to antibody-drug conjugates gives investors a seat at one of the hottest tables in cancer treatment. 

In February 2026, AstraZeneca said Datroway received Priority Review in the United States for first-line metastatic triple-negative breast cancer in patients who are not candidates for immunotherapy, based on results showing significantly improved overall survival versus chemotherapy. 

That’s a strong signal that these smarter payload-delivery systems are not just interesting science projects anymore. They’re increasingly looking like future standards of care. 

These kinds of names usually won’t give you the crazy overnight upside of a tiny small-cap biotech. But they do give you something most small biotechs don’t: durability…

You can own them without feeling like one bad headline is going to send the whole position into a crater. 

And for a lot of investors, that’s exactly where the foundation of an oncology portfolio should start.

Where Things Get Interesting

Once you move beyond the giant pharma names, the upside starts to get a lot more exciting. But it also gets a bit more hazardous…

Revolution Medicines is one of the names that stands out most to me in that category. 

The company is targeting the RAS pathway, one of the most important and historically frustrating targets in all of oncology. 

For years, these mutations were viewed as some of the hardest problems in cancer drug development. Now Revolution is pushing a late-stage pipeline aimed right at that opportunity. 

In February 2026, the company said it remained on track for a pivotal first-half 2026 readout from its Phase 3 trial in second-line metastatic pancreatic cancer, while also advancing a broader late-stage pipeline that includes five ongoing Phase 3 trials and plans for three more to start in 2026. 

That is exactly the kind of setup growth-oriented healthcare investors look for…

Big addressable market. Serious scientific rationale. A clinical catalyst with the potential to materially rerate the stock. 

This doesn’t make Revolution a sure thing. Nothing in oncology is a sure thing. But it does make it one of the more credible higher-beta names in the group.

This is the sweet spot where the market often misprices opportunity. A company is no longer a science experiment, but it still hasn’t fully earned blue-chip credibility. 

That gap between promise and acceptance is where some of the best returns can come from.

The Real “Lottery Ticket” Zone

Then you get down to the truly speculative names, and this is where GT Biopharma comes in.

This is not a conservative stock. This is not a “set it and forget it” investment. This is a nano-cap oncology speculation with all the risk that comes with that label. 

But it also has something speculative investors are always looking for: a real, near-term clinical setup tied to a differentiated approach.

GT Biopharma is developing TriKE technology, short for tri-specific killer engager, designed to harness natural killer cells against cancer. 

In February 2026, the company announced FDA clearance of its IND for GTB-5550, a targeted natural killer cell engager for solid tumors, and said a Phase 1 dose-escalation basket trial is expected to begin in mid-2026. 

That’s not fluff. That’s a meaningful milestone for a company of this size. 

But, let’s be adults about this. A tiny company with an early-stage program can absolutely produce enormous upside if the data start to line up. 

It can also dilute shareholders, stumble operationally, or disappoint in the clinic. Both things are true. 

Still, this is exactly the kind of name that can transform a portfolio when it works. You just have to size your position like a rational human.

Why The Basket Matters More Than the Story

The temptation in biotech is always to fall in love with a story…

Investors hear a slick pitch, memorize a few scientific acronyms, and start acting like they’ve found the next ten-bagger with absolute certainty. 

But oncology has a way of humbling that kind of confidence.

That’s why the basket matters more than any single narrative. You want exposure to several different types of cancer-treatment innovation at once. 

You want a few larger names with established franchises. But, you also want a few mid-sized names with strong pipelines and major upcoming catalysts. 

And then, if your risk tolerance allows it, you want a couple of small speculative shots with truly asymmetric upside.

That framework is what makes the whole idea work. 

It lets you participate in a field where one winner can create enormous value without forcing you to pretend you know exactly which company will get everything right. 

And let’s be honest, in a field as complex as cancer treatment, it’s tough to know anything with certainty until the results are in.

Build The Portfolio Before Everyone Else Does

Here’s the bottom line: Oncology is one of the richest long-term opportunity sets in the market.

The problem is massive, the science is improving, and the companies making genuine progress can become incredibly valuable. 

The market will eventually reward the businesses that prove they can extend survival, move treatments earlier in care, or open up entirely new ways of fighting tumors. 

We’re already seeing that happen in radioligands, antibody-drug conjugates, and targeted precision oncology. 

The key for retail investors is not to wait until everything feels obvious and comfortable. By then, the easy gains are usually gone. 

The key is to start building exposure now, thoughtfully and with discipline. 

Own some of the bigger names for stability. Add some mid-tier innovators for upside. Sprinkle in a few moonshots if you can stomach the volatility. 

Then let time, clinical progress, and portfolio construction do the work.

That’s the real play here. Not chasing one miracle. Building yourself a portfolio of potential cancer cures.

Don’t just watch this theme from the sidelines while Wall Street circles around the next generation of oncology winners. 

Start building your basket. Start doing the work. Start putting capital behind the companies trying to change the future of cancer treatment. 

Because if even a handful of these platforms deliver, the medical upside will be enormous, and the investment upside could be, too.

The market still talks about AI like it’s mostly a software story. 

Better models. Faster chips. Smarter applications. Bigger cloud contracts. 

All of that matters. But the deeper story now is electricity…

AI infrastructure is turning into a power business wrapped inside a technology business, and Washington knows it.

The Real AI Race

The Trump White House has spent the past year pushing an aggressively pro-build posture on both energy and AI. 

It has made clear that it wants America to dominate the next generation of digital infrastructure, but it has also made clear that ordinary households should not be forced to foot the bill for that ambition. 

That’s the key point. 

Washington is not saying slow down. It’s saying build faster, but build smarter.

And that changes the investment map in a big way… 

If data center developers can no longer just show up, plug into a stressed grid, and let rate structures absorb the pain later, then location becomes everything. 

The first big winners in this buildout are likely to be the companies that already understand one brutal truth…

The best AI site is not necessarily the one closest to the biggest city. It’s the one closest to the best power.

Power Is the Moat

Everybody wants to talk about demand, and yes, demand is enormous. But demand without deliverable electricity is just a pitch deck. 

The real bottleneck is not whether companies want more compute. Of course they do. 

The real bottleneck is whether enough reliable power can be brought online fast enough, cheaply enough, and politically cleanly enough to support that compute.

That’s where the moat starts to form. 

If you can build right beside abundant generation—or in a region where low-cost power already exists—you solve problems that other developers are still pretending aren’t there. 

You reduce grid friction. 

You shorten energization timelines. 

You make project economics easier to finance. 

And in a market where speed matters almost as much as scale, that advantage is massive.

This is why co-location has become such an important concept…

The companies that can pair massive compute demand with dedicated or advantaged supply are going to have the inside track. 

Everybody else may still get there eventually, but they’ll arrive later, spend more money getting there, and face more regulatory and political resistance along the way.

Where the Extra Power Lives

So where does this extra power actually exist? 

Start with hydroelectric regions… 

Big hydro offers stable, dispatchable electricity, and some of the best hydro corridors in North America have already been attracting power-hungry infrastructure for years. 

That’s not an accident. 

Cheap, dependable electricity tends to attract industries that care more about megawatts than zip codes.

Then there’s nuclear… 

For a long time, nuclear was treated like yesterday’s story. Today it looks a lot more like tomorrow’s backbone. 

AI workloads are relentless. They don’t want intermittent supply. They want dense, always-on power, and nuclear fits that description almost perfectly. 

A data center next to a reactor has a very different strategic profile than one sitting at the end of a crowded transmission line hoping for upgrades.

And then there’s geothermal, which may be one of the most underappreciated pieces of this entire puzzle… 

Unlike wind and solar, geothermal can run around the clock. 

Unlike large nuclear projects, it can sometimes be scaled in ways that fit regional growth more flexibly. 

Places with strong geothermal potential could become much more important to AI infrastructure than most investors currently realize.

And the market is slowly starting to understand this. 

The race isn’t just to build data centers. It’s to build them where the electrons already exist, or where they can be added with the least friction and the greatest certainty.

Nuclear Next Door

Amazon has already shown the market what this looks like in practice… 

Its move to secure data center infrastructure next to nuclear power in Pennsylvania wasn’t some random real estate decision. It was a power-first strategy hiding in plain sight.

If you’re a hyperscaler staring down years of rising AI demand, you do not want to sit around waiting to find out whether the local grid can support your next wave of expansion. 

You want direct proximity to a massive, dependable, around-the-clock source of electricity. 

You want a cleaner line of sight on supply. And you want less uncertainty. 

That’s what nuclear adjacency gives you.

Microsoft has been reading from the same playbook… 

Its support for bringing major nuclear capacity back into the conversation is one of the clearest signs that serious AI players are willing to go well beyond simply buying electricity off the grid. 

They are thinking about how to make sure the power exists in the first place.

That’s an important shift. 

The biggest AI infrastructure players are no longer acting like passive utility customers. 

They are becoming active architects of the energy systems they need. 

Investors should pay close attention when companies with essentially unlimited capital start behaving like that. 

They are telling you where the bottleneck is, and they are telling you how they plan to solve it.

Hot Rock, Cold Cash

Google has been moving down a slightly different path, but toward the same destination… 

Its geothermal efforts show how hyperscalers are trying to anchor data center growth to power sources that can run day and night without depending on the weather. 

That’s a smart strategy in any environment. In one where Washington wants AI expansion without ratepayer pain, it becomes even smarter.

Geothermal doesn’t get the same flashy headlines as nuclear restarts or giant gas plants, but it may end up being one of the quiet winners of this whole cycle. 

It offers reliability. It offers scalability in the right regions… 

And it offers a way to support major compute loads without leaning too heavily on already strained grid infrastructure.

The companies that figure this out early won’t just get cheaper electricity. 

They’ll get time. They’ll get optionality. They’ll get a smoother permitting story. They’ll get the ability to expand with fewer headaches. 

And in a market where demand is exploding and everybody wants capacity yesterday, that optionality is worth a fortune.

The Hydro Advantage

Not every winner in this story is going to be a household-name hyperscaler…

Some of the clearest beneficiaries may be the operators that spent years building in places where cheap, dependable hydro power was already available.

That’s the logic behind the long-standing data center clusters in the Pacific Northwest and other hydro-rich regions. 

These operators understood something years before the broader market started waking up to it: power matters more than glamour. 

A flashy site near a major metro might look great in a presentation, but a site sitting on top of some of the cheapest and most reliable electricity in North America is often a far better business.

Sabey is a good illustration of that logic… 

Its Columbia campus wasn’t built around hype. It was built around access to hydro. 

That’s the kind of decision that may have looked boring to some investors a few years ago. 

Today it looks like foresight. 

As the AI buildout pushes deeper into the power question, companies that already staked out hydro-rich territory may find themselves holding much more strategic assets than the market once gave them credit for.

BitZero Saw This Coming

Then there’s BitZero, which is where this story gets especially interesting for investors willing to look before the crowd fully catches on. 

BitZero is not trying to become just another generic AI infrastructure name with a big narrative and not much underneath it. 

The company has spent years assembling a global network of data center operations tied to advantaged power, especially hydroelectric power, and now it’s working to build more of that same model in the United States.

That matters because BitZero is approaching the market from the right end of the problem. 

It’s not starting with a land parcel and then hoping the electricity shows up. It’s starting with energy logic and building the compute opportunity around that. 

In a market where access to abundant power is becoming one of the core constraints, that is exactly the kind of positioning investors should be paying attention to.

A lot of small companies talk about opportunity. Far fewer have infrastructure, relationships, operating experience, and a strategy that lines up cleanly with where the market is actually headed. 

BitZero’s global network near excess hydroelectric supply gives it a head start in a world that is suddenly placing a premium on exactly that kind of footprint. 

If the market starts re-rating power-first operators as strategic AI infrastructure plays, BitZero could find itself in a much brighter spotlight.

The Early Winners

This is the part I don’t think the broader market fully appreciates yet… 

In the early phase of an infrastructure boom, investors usually chase the most visible names first. 

They buy the chip giant. They buy the most famous cloud operator. They buy the software platform everybody already knows. 

Sometimes that works. But the bigger asymmetrical gains often come from identifying the bottleneck before everyone else does.

Right now, that bottleneck is not interest in AI. Nobody needs to be convinced that AI demand is real. 

The bottleneck is power that can actually be delivered, in the right place, on the right timeline, without creating political blowback or hammering ratepayers.

That means the premium may accrue first to the companies that already built their models around that reality… 

The operators sitting near dams. The hyperscalers striking deals near nuclear assets. The developers leaning into geothermal regions. 

The smaller firms like BitZero that understood early that the future of compute would be constrained not by imagination, but by megawatts.

That does not mean every company with a “power” slide in its investor deck is a winner. 

Plenty will overpromise. Plenty will discover that transmission, permits, and execution are harder than they expected. 

But the category itself is real. The shift is real. And the companies already positioned around excess or advantaged power are likely to be the biggest initial beneficiaries.

Before the Crowd Catches On

This is one of those moments when the market is giving you a clue… 

Washington wants rapid AI expansion. It wants the United States to dominate the sector. 

But it also wants that expansion to happen without driving up electricity costs for ordinary Americans. 

That pushes the entire industry toward a smarter model, one where data center demand is paired with dedicated supply or located near regions where abundant power already exists.

That’s not background noise. That’s the thesis.

So, pay attention to the companies already sitting on power-rich ground. 

Pay attention to the operators building near hydro dams, nuclear plants, and geothermal resources. 

Pay attention to the smaller names the market has not fully re-rated yet, especially the ones that already have real infrastructure and real plans in motion.

Because once Wall Street fully realizes that the first true winners of the AI buildout are not just the firms with the best models, but the firms with the best megawatts, the easy gains won’t be easy anymore. 

Learn more now. Do the work now. And get invested before the market figures out who the real winners are and reprices them accordingly.

Hint: When sentiment overwhelms the facts, it might be time to take a closer look.

This week, a press release went out that handed the market exactly the kind of biotech story investors claim they want.

A company released new data on its experimental treatment for generalized anxiety disorder, and on the surface the readout looked compelling. 

Adults with moderate-to-severe anxiety, despite already taking standard antidepressants, received just two injections spaced three weeks apart. 

Layered on top of existing medication, the higher-dose regimen produced a double-digit reduction on a major anxiety scale by week six. 

Better yet, the benefit appeared durable out to six months. No serious drug-related side effects were reported.

For a patient population that has often already cycled through SSRIs, SNRIs, and the rest of psychiatry’s usual toolbox, this treatment looked less like an interesting lab experiment and more like a potentially meaningful new option.

And yet the stock got crushed.

On the same day the company shared the data, its shares fell roughly a third on heavy volume.

That kind of move tends to trigger one immediate conclusion: something must be wrong.

But that conclusion may be too simple. 

Because when you look past the shock of the one-day decline and examine the setup into the event, a different interpretation starts to emerge. 

In the days before the announcement, the company — Helus Pharma (NASDAQ: HELP) had already staged a sharp speculative run into the $8-plus area, a zone that has repeatedly acted as resistance over the past year. 

The stock ran hard into the catalyst press release.

It hit a known resistance area, then snapped back toward a well-established support band. 

But that does not automatically suggest a broken story. 

It may simply suggest a crowded trade unwinding.

Because many traders in small-caps like Helus Pharma (NASDAQ: HELP) are not buying with a five-year horizon. They are buying because there is a date on the calendar. They want anticipation. They want momentum. They want a catalyst pop.

So they load up days or weeks before the event, ride the run, and often sell into the release no matter what the data says.

If those traders bought in the upper $5s and watched the stock rip into the $8s ahead of the announcement, then a positive readout was not necessarily a reason to hold … It was a liquidity event. 

In other words, the market’s message may not have been, “The science failed.”

It may have been, “The trade worked.”

That is a very different thing.

And the actual content of Helus’s release leans in that direction.

So, clearing away the market noise, what does the release actually say?

The company reported statistically significant efficacy. 

It showed roughly a 10-point improvement on a validated anxiety measure. It demonstrated durability out to six months. 

It reported clean tolerability, with no serious drug-related adverse events and no suicide-related safety signals flagged.

Objectively, that is the kind of dataset many development-stage biotechs would be thrilled to own.

But markets do not reward news in a vacuum. They reward news relative to expectations.

And expectations, especially in small-cap biotech, rarely stay grounded for long.

And once that sentiment shifted, other familiar small-cap forces likely added fuel to the decline.

The float is limited. Retail participation is high. That means emotion travels fast.

Once the stock lost the $7 area, stop-loss selling likely kicked in. That kind of forced selling can turn a retreat into a rout. Add in a shareholder base full of event-driven traders, and suddenly the exit door gets crowded fast.

That does not mean the business deteriorated overnight.

It means traders saw a reason to protect gains while liquidity was available.

The real question is whether anything in the actual data release meaningfully damaged the long-term thesis.

Did HLP004 suddenly stop looking relevant for treatment-resistant anxiety?

Did the company reveal a new safety concern that changes the risk-reward equation?

Did the efficacy signal come in weak or ambiguous?

So far, the answer appears to be no.

The signal still looks meaningful. The durability remains notable, especially for such a light-touch dosing schedule. And the safety profile, at least in this early cohort, appears manageable.

If the underlying probabilities have not changed much, then what investors may be watching now is not a collapse in fundamentals but a washout in sentiment.

And those are not the same thing.

In fact, the best “buy the dip” opportunities often show up precisely when the market confuses the two.

A failed trial is not a dip to buy.

A new safety problem is not a dip to buy.

A regulatory setback is not a dip to buy.

But a stock that gets hit because traders had already front-run the news, because expectations became inflated, because stop-losses cascaded, and because dilution anxiety spiked?

That can be very different.

That can be the kind of mess long-side investors learn to study instead of fear.

If Helus Pharma (NASDAQ: HELP) can stabilize around its historical support band in the mid-$5s and start reclaiming the low-$6s, the selloff will increasingly look like what it probably was: a fast-money reset after an overextended catalyst run.

But as of now, the broader story still looks intact.

HLP004 still represents a notably different treatment model in anxiety: two closely supervised clinic visits instead of years of daily pill burden. A short period of intense psychoactive intervention followed, in some patients, by months of relief. A setup that could fit neatly into the growing ecosystem of clinic-based mental-health care, particularly for severe patients where payers have already shown a willingness to reimburse more intensive treatment models.

Helus also still has a related depression program built around the same short-course, durable-reset philosophy.

And it still operates in a large, underserved market filled with patients who do not feel well-served by conventional options.

Helus may be one of those cases where the market is simply emotional, crowded, impatient, and allergic to anything that falls short of fantasy.

And if it is, then this week’s plunge may ultimately be remembered not as the moment the story broke, but as the moment sentiment temporarily buried the fundamentals.

That is often where the best dip-buying opportunities begin.

IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This paid advertisement includes a stock profile of Helus Pharma (NASDAQ: HELP). Rebel Investors Club is an investment newsletter being advertised herein. This paid advertisement is intended solely for information and educational purposes and is not to be construed under any circumstances as an offer to sell or a solicitation of an offer to purchase any securities. In an effort to enhance public awareness, Helus Pharma (NASDAQ: HELP) provided advertising agencies with a total budget of approximately $2,914,712 and is the sole source of funds to cover the costs associated with creating, printing and distribution of this advertisement.  From that total budget, Moneta Advisory Partners, an affiliate of Rebel Investors Club was paid $500,000 as a research fee and for the production and placement of additional advertising media for this campaign. The advertising agencies will retain any excess sums after all expenses are paid. Rebel Investors Club may receive subscription revenue in the future from new subscribers as a result of this advertisement for its newsletter.

While this advertisement is being disseminated and for a period of not less than 90 days thereafter, Rebel Investors Club , the advertising agencies, and their respective officers, principals, or affiliates will not sell securities of Helus Pharma (NASDAQ: HELP). If successful, this advertisement will increase investor and market awareness of Helus Pharma (NASDAQ: HELP) and its securities, which may result in an increased number of shareholders owning and trading the securities, increased trading volume, and possibly an increase in share price, which may be temporary. This advertisement, the advertising agencies and Rebel Investors Club do not purport to provide a complete analysis of Helus Pharma (NASDAQ: HELP) or its financial position. They are not, and do not purport to be, broker-dealers or registered investment advisors. 

This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a registered broker-dealer or registered investment advisor or, at a minimum, doing your own research if you do not utilize an investment professional to make decisions on what securities to buy and sell, and only after reviewing the financial statements and other pertinent publicly-available information about Helus Pharma (NASDAQ: HELP). Further, readers are specifically urged to read and carefully consider the Risk Factors identified and discussed in Helus Pharma (NASDAQ: HELP) SEC filings. Investing in microcap securities such as Helus Pharma (NASDAQ: HELP) is speculative and carries a high degree of risk. Past performance does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the advertising agencies and Rebel Investors Club cannot guarantee the accuracy or completeness of the information and are not responsible for any errors or omissions. 

This advertisement contains forward-looking statements, including statements regarding expected continual growth of Helus Pharma (NASDAQ: HELP) and/or its industry. The advertising agencies and Rebel Investors Club note that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect Helus Pharma (NASDAQ: HELP) actual results of operations. Factors that could cause actual results to vary include the size and growth of the market for Helus Pharma (NASDAQ: HELP) products and/or services, the company’s ability to fund its capital requirements in the near term and long term, federal and state regulatory issues, pricing pressures, etc. 

Rebel Investors Club is the publisher’s trademark. All trademarks used in this advertisement other than Rebel Investors Club are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. The advertising agencies and Rebel Investors Club are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks. 

This past weekend’s confrontation involving the United States and Israel wasn’t just another chapter in modern conflict. It was a preview…

Yes, there were aircraft, missiles, drones, and explosions — the things war has always relied on to send a message. 

But beneath the surface, running in parallel, was something far more consequential…

When the First Strike Isn’t a Bomb, It’s a Line of Code

A digitally coordinated campaign where cyber operations and artificial intelligence worked hand-in-hand with physical force.

That’s the part most headlines glossed over. And it’s the part investors need to understand.

Because the future of warfare isn’t tanks or keyboards. It’s both. Simultaneously. Integrated. Relentless.

And if that’s how wars are fought, then defending digital infrastructure is no longer an IT expense. It’s a national security imperative.

Modern War No Longer Begins at the Border

Traditional war had a starting line. Troops crossed borders. Aircraft crossed airspace. Naval fleets crossed horizons.

Digital war has no such courtesy… 

By the time the first missile launches, the real work is often already done. 

Networks have been probed. Systems mapped. Communications degraded. Confusion seeded. Decision-makers delayed. Data corrupted. Signals distorted.

And what unfolded over the past weekend followed a pattern military planners have been perfecting for years: weaken the digital nervous system first, then strike the physical body.

AI now accelerates that process beyond anything humans could manage alone. 

It ingests vast streams of intelligence, detects vulnerabilities in real time, and helps planners model cascading effects — not just on targets, but on responses.

This isn’t science fiction. It’s simply what happens when computing power collides with geopolitics.

The Fusion of AI and Cyberwarfare Changes Everything

Cyberwarfare used to be disruptive. Annoying. Sometimes destructive.

AI turns it into something else entirely.

Artificial intelligence allows attackers — and defenders — to operate at machine speed. 

Networks can be scanned continuously. Threats classified instantly. Countermeasures deployed automatically. False signals identified. Anomalies flagged before humans even notice something is wrong.

In a battlefield environment, this means physical strikes are no longer isolated events… 

They are synchronized moments in a much larger system — one where digital pressure shapes physical outcomes.

Disable communications at the right moment and air defenses hesitate. 

Corrupt logistics data and resupply slows. 

Confuse command systems and response times stretch just long enough for kinetic strikes to land cleanly.

This is digital warfare as a force multiplier.

And once that threshold is crossed, there’s no going back.

America’s Real Vulnerability Isn’t Missiles — It’s Infrastructure

Here’s where investors need to lean forward…

The United States doesn’t need to worry most about tanks rolling across borders. 

It needs to worry about attacks on power grids, financial networks, telecommunications systems, transportation hubs, water systems, and data centers.

Those are the arteries of modern society.

They are also digital.

The same techniques used overseas — AI-driven intrusion detection, automated network disruption, signal manipulation — can be turned inward by adversaries who understand that paralyzing infrastructure is often more effective than direct military confrontation.

The uncomfortable truth is this: America’s greatest strength — its technological integration — is also its greatest exposure.

And defending that exposure at scale is impossible without artificial intelligence.

Cybersecurity Is No Longer a Software Category — It’s a Defense Sector

For years, cybersecurity was treated like plumbing… 

Necessary, invisible, unexciting. A line item, not a strategy.

But that era is over.

AI-powered cybersecurity is now part of the national defense stack. Just as radar defined air defense in the 20th century, intelligent cyber defense defines security in the 21st.

Why? Because human analysts simply can’t respond fast enough. 

They can’t monitor millions of endpoints simultaneously. They can’t anticipate novel attack patterns without machine learning models trained on oceans of data.

AI doesn’t just defend against known threats…

It identifies unknown ones — the zero-day exploits, the behavioral anomalies, the subtle deviations that signal something is wrong before damage spreads.

That capability isn’t a luxury. It’s table stakes.

The Military Lesson Investors Shouldn’t Ignore

Wars have always accelerated technological adoption…

Radar. Jet engines. Satellites. Nuclear power. GPS. The internet itself.

What we’re seeing now is the militarization of AI-driven cybersecurity — and once that happens, civilian adoption follows fast.

Defense budgets don’t fund experiments. They fund deployment.

When governments begin integrating AI cyber tools into military doctrine, those same technologies quickly find their way into energy systems, financial institutions, healthcare networks, and industrial operations.

The implication is simple: cybersecurity companies that can operate at machine speed, at national scale, and under hostile conditions are no longer niche tech plays. 

They are strategic assets.

And strategic assets tend to get funded, contracted, and prioritized — regardless of economic cycles.

The Quiet Arms Race Happening Behind the Screens

There’s an arms race underway that never appears on missile-count charts.

It’s measured in model accuracy, response latency, detection rates, false positives avoided, and automated containment success.

Adversaries aren’t just building weapons…

They’re building algorithms. They’re training systems to evade detection, mimic normal behavior, and exploit trust relationships between machines.

Defending against that requires systems that learn faster than attackers can adapt.

This is why AI is not an add-on to cybersecurity anymore. It’s the core.

And it’s why the winners in this space won’t necessarily be the loudest brands — they’ll be the ones embedded deep inside critical systems, invisible until something tries to break them.

From Battlefield to Balance Sheet

Investors often ask me how to spot long-term themes before Wall Street fully prices them in.

Here’s one: the convergence of AI, cybersecurity, and national defense.

It’s not cyclical. It’s structural.

Geopolitical instability doesn’t reduce digital risk — it multiplies it. 

Every conflict increases the incentive to probe, disrupt, and exploit digital systems far beyond the physical battlefield.

That means spending doesn’t retreat when wars end. It expands.

Budgets shift from reactive defense to continuous monitoring…

From static firewalls to adaptive intelligence… 

From human-centered workflows to autonomous response systems.

And once those systems are in place, ripping them out isn’t an option.

Why This Moment Matters More Than Headlines Suggest

What happened this weekend wasn’t just a tactical operation. It was a signal…

It said: future conflicts will be fought across networks as much as across terrain. 

Victory will depend as much on algorithms as on aircraft. And resilience will matter more than raw firepower.

For investors, this reframes cybersecurity entirely.

You’re no longer investing in protection from hackers. You’re investing in the digital immune system of nations.

That’s a much bigger idea.

And historically, when markets finally understand ideas like that, valuations follow.

The New Reality: Digital Defense Is National Defense

The most important takeaway isn’t which systems were used, or which tools were deployed, or which models ran in the background.

It’s that the line between cyber and kinetic warfare is gone.

Digital attacks now shape physical outcomes. Physical strikes rely on digital dominance. And artificial intelligence is the glue binding them together.

For the United States, defending digital infrastructure is no longer a secondary concern. It is the frontline.

For investors, understanding that shift — early — is how you position ahead of one of the most durable, government-backed, mission-critical investment themes of the next decade.

The invisible front is here. And it’s not going away.

Stay alert. Stay early. Stay positioned.

The strategic narrative around space just shifted again. 

During a February 23, 2026 stop in Denver as part of the Department of War’s “Arsenal of Freedom” tour, Secretary of War Pete Hegseth declared space “the ultimate high ground — the single most decisive battlefield of this century.” 

That message comes as Congress has already approved $839 billion in defense spending for fiscal 2026, including billions earmarked for missile warning, tracking satellites, and integrated space and missile defense systems. 

Public companies operating at the intersection of commercial launch and national security — including Starfighters Space (NYSE-A: FJET), Rocket Lab (NASDAQ: RKLB), L3Harris Technologies (NYSE: LHX), Intuitive Machines (NASDAQ: LUNR), and Northrop Grumman (NYSE: NOC) — are increasingly positioned at the center of that shift.

The War Department’s remarks in Colorado underscored an urgency to broaden the defense industrial base beyond traditional primes. Speaking to workers at commercial space companies, Hegseth emphasized the need to “open the aperture” and accelerate innovation, stating, “Whoever controls space, controls the future fight; it’s that simple.” For investors, that messaging reinforces a structural theme: national security is driving sustained demand for launch capacity, resilient satellite constellations, hypersonic testing, and missile tracking infrastructure.

Starfighters Space (NYSE-A: FJET) is one of the smaller, newly public entrants aligned with this trend. 

Based at NASA’s Kennedy Space Center, the company operates modified supersonic aircraft designed to serve as first-stage air-launch platforms under its STARLAUNCH system. Recently, the company completed subsonic and supersonic wind tunnel testing for STARLAUNCH 1 at Mach 0.85 and Mach 1.3, validating clean separation behavior across flight regimes and correlating results with its computational models. 

The company also initiated procurement of an instrumented demonstrator vehicle for underwing flight testing and is preparing for a Critical Design Review. “As we move into the commercialization era of our business, we are grateful for the strong foundation, both operationally and financially, [founder Rick Svetkoff] has left us,” said CEO Tim Franta, following his appointment after the company’s NYSE listing. 

The milestone testing and leadership transition signal a shift from concept validation toward execution and commercialization.

Rocket Lab (NASDAQ: RKLB) continues to expand its role in national security space. 

The company is preparing to launch its Cassowary Vex mission using its HASTE rocket platform for the Department of War’s Defense Innovation Unit. 

The mission will deploy a scramjet-powered test vehicle developed by Hypersonix, marking the company’s fourth hypersonic test launch in under six months. 

Rocket Lab also holds more than $1.3 billion in contracts from the Space Development Agency (SDA), including an $816 million award to build 18 missile defense satellites equipped with next-generation infrared sensors for the Tracking Layer Tranche 3 program. 

The company has stated that its vertically integrated model enables faster delivery and lower costs — a structure that aligns with the War Department’s call for speed and execution in strengthening the industrial base.

L3Harris Technologies (NYSE: LHX) recently reorganized its business from four segments to three, creating a dedicated Space & Mission Systems unit following an $843 million SDA contract to build 18 infrared satellites for Tracking Layer Tranche 3. 

The restructuring consolidates missile warning, missile defense, and space payload capabilities under a unified structure. “This change thoughtfully organizes common business models, technical capabilities and investment priorities,” said Chairman and CEO Christopher Kubasik. The company currently has four missile tracking satellites on orbit for Tranche 0 and dozens more in development, reinforcing its role in proliferated space architecture.

Intuitive Machines (NASDAQ: LUNR) completed its $800 million acquisition of Lanteris Space Systems (formerly Maxar Space Systems), combining $450 million in cash and $350 million in stock. 

The deal expands the company into vertically integrated spacecraft manufacturing and strengthens its ability to compete for SDA and NASA programs. “This acquisition marks a defining moment in the evolution of Intuitive Machines,” said CEO Steve Altemus. “We previously proved our ability to operate on the Moon. With Lanteris, we add flight-proven manufacturing at scale.” 

The combined entity reports over $850 million in revenue and approximately $920 million in backlog, positioning it for broader participation in national security and lunar initiatives.

Northrop Grumman (NYSE: NOC) was selected as one of four prime contractors under the SDA’s $3.5 billion Tranche 3 Tracking Layer program. 

The company is responsible for a significant portion of the 150 satellites planned across the first three tranches of the Proliferated Warfighter Space Architecture. “Northrop Grumman’s contributions to both high and low altitude layers of our nation’s missile warning and tracking architecture help protect our nation from a wide range of threats,” said Brandon White, Vice President of Space-Enabled Multi-Domain Operations. 

The company projects its Space Systems segment to reach approximately $11 billion in fiscal 2026, reflecting increasing demand for missile warning and space-based sensing.

While larger primes and established launch providers command substantial contracts, Starfighters Space (NYSE-A: FJET) represents an earlier-stage entrant that directly aligns with the War Department’s message about expanding the competitive field. 

As Hegseth emphasized in Denver, “We can’t just rely on the big [defense contractors]… We have to open the aperture and ensure that scrappy companies that have great ideas… are able to compete on a level playing field.” 

For smaller, specialized launch companies, that policy tone could translate into increased testing, prototyping, and niche mission opportunities.

Starfighters’ differentiator centers on its air-launch model. 

The company states it is the only commercial operator capable of sustained Mach 2 flight for payload carriage, enabling rockets to be deployed from approximately 45,000 feet. This approach can offer flexibility in launch azimuth, weather avoidance, and rapid mission scheduling compared to fixed-pad systems. 

Recent wind tunnel validation at both subsonic and supersonic speeds reduces aerodynamic risk ahead of fabrication and integration. The upcoming Critical Design Review supported by GE Aerospace represents a formal engineering milestone before advancing to hardware production.

In terms of operational traction, Starfighters has increased visibility following its public listing and rang the Opening Bell at the New York Stock Exchange. 

Leadership continuity also appears to be a focus. Former Congressman Bill Posey, who represented Florida’s Space Coast for over a decade, endorsed the CEO transition, stating, “It is very fitting that [Franta] now leads a company that aims to continue that development.” Franta himself brings more than two decades of experience in space commercialization, including roles tied to FAA licensing and infrastructure funding in Florida.

From a competitive standpoint, air-launch systems face high technical and regulatory barriers. Integration with supersonic aircraft, FAA launch licensing, propulsion validation, and aerodynamic separation testing all represent specialized engineering domains. 

Starfighters’ proximity to Kennedy Space Center and its experience operating modified supersonic aircraft provide a foundation that may be difficult for new entrants to replicate quickly. 

As missile defense architectures increasingly require responsive launch and testing capabilities, flexibility and speed could become strategic advantages.

Looking ahead, near-term catalysts for Starfighters include completion of its Critical Design Review, progression into fabrication and integration of STARLAUNCH 1, and further underwing flight testing of its instrumented demonstrator vehicle. 

Broader sector catalysts include continued Space Development Agency tranche awards, hypersonic test demand, and execution of recently funded defense budgets emphasizing space dominance.

The macro thesis remains clear: national security priorities are accelerating investment in launch, tracking, and resilient space infrastructure. Rocket Lab, L3Harris, Intuitive Machines, and Northrop Grumman each represent scaled platforms benefiting from defined contract backlogs. 

Starfighters Space, while earlier in its commercialization arc, is positioning itself within that same structural shift — one increasingly reinforced by explicit policy messaging from the highest levels of defense leadership.

 Disclaimer: This is a paid marketing advertisement for informational purposes only and should not be construed as personalized investment advice. The Investment Journal is not a registered broker-dealer or investment advisor and is published on behalf of Creative Direct Marketing Group (“CDMG”), which is affiliated with The Investment Journal for advertising and investor awareness services. CDMG may also be compensated by the featured company or other third parties, creating a material conflict of interest. Third parties, including company insiders or shareholders, as well as The Investment Journal and its affiliates, may buy or sell securities of the featured company at any time without notice, which may impact the market price. Information presented is believed to be reliable but is not guaranteed as to accuracy or completeness, and forward-looking statements involve risks and uncertainties. Investing in securities involves substantial risk, including the possible loss of principal. Conduct your own due diligence and consult a licensed financial professional before making any investment decision. 

SOURCES:

1.) Company press releases and filings from Starfighters Space, Rocket Lab, L3Harris Technologies, Intuitive Machines, and Northrop Grumman (2025–2026).

2.) Department of War, “Hegseth, Arsenal of Freedom Tour Look to Space From ‘Mile High City’,” Feb. 23, 2026.

3.) Air & Space Forces Magazine, “Congress Passes $839 Billion Budget for Defense.”

Every bull market needs a good panic. And every panic needs a good story.

Right now, the story hitting cybersecurity stocks goes something like this.. 

“AI is going to replace traditional cybersecurity tools, make entire business models obsolete, and permanently shrink the opportunity.”

So, investors sell first and ask questions later.

Share prices fall. Valuations compress. Headlines scream disruption. 

And suddenly a sector that was “mission-critical” six months ago is being treated like yesterday’s antivirus CD-ROM.

I’ve seen this movie before. 

And spoiler alert: it usually ends with patient investors getting paid.

Because the truth is much less dramatic — and far more bullish…

The recent selloff in cybersecurity stocks isn’t a reflection of collapsing fundamentals. 

It’s a fear-driven valuation reset based on a misunderstanding of how AI actually changes the security landscape. 

In reality, artificial intelligence doesn’t reduce the need for cybersecurity. It supercharges it.

And that’s exactly why this dip deserves a closer look…


The Fear: “AI Makes Cybersecurity Obsolete”

Markets are great at two things: extrapolating trends and overreacting to them.

AI is the hottest trend on the planet right now… 

So investors naturally ask: If AI can write code, detect anomalies, and automate responses, why do we need legacy cybersecurity vendors at all?

Layer on a few breathless think-pieces about autonomous AI agents defending networks on their own, and suddenly you have a neat narrative…

Traditional cybersecurity tools are outdated, margins are at risk, and growth is about to slow.

That narrative is powerful… And also deeply flawed.

It assumes cybersecurity is a static problem that AI solves once and forever. But, in reality, cybersecurity is an arms race. 

And we all know that AI doesn’t end arms races… it accelerates them.


The Reality: AI Is Fuel for the Cyber Arms Race

Here’s the part the market is glossing over: AI empowers attackers just as much as defenders — often more.

Malicious actors are already using AI to:

• Generate polymorphic malware that constantly changes its signature
• Launch hyper-personalized phishing attacks at massive scale
• Probe networks faster and more intelligently than any human team could
• Automate vulnerability discovery across vast digital surfaces

AI doesn’t reduce threats. It multiplies them.

Every new AI model deployed inside a company becomes another attack surface. 

Every automated workflow creates new vulnerabilities. 

Every connected device and API endpoint expands the blast radius.

The result? The complexity of securing digital infrastructure explodes.

That’s not bad news for cybersecurity companies. That’s oxygen.


Why “Traditional” Cybersecurity Isn’t Going Away

Another mistake embedded in the selloff is the idea that cybersecurity companies are standing still.

But they’re not…

The best firms in this space are aggressively integrating AI into their platforms — not as a replacement, but as a force multiplier. 

AI-driven threat detection, behavioral analytics, automated response systems, and predictive modeling are becoming standard features, not optional upgrades.

This isn’t a disruption story. It’s an evolution story.

Firewalls didn’t disappear when cloud computing arrived — they adapted. 

Endpoint security didn’t vanish when mobile devices exploded — it expanded. 

And cybersecurity won’t fade because AI exists — it will embed AI at its core.

In fact, companies that don’t incorporate AI into their defenses are the ones at risk. 

The leaders are already doing the opposite: using AI to spot threats faster, respond smarter, and scale protection across environments humans can’t manually monitor.

That’s why the idea of “obsolete cybersecurity” misses the mark entirely.


The Market’s Short-Term Vision Problem

Markets love clean, linear stories. AI breaks old models, therefore old companies lose. 

Simple. Elegant. Wrong.

What we’re actually seeing is a classic short-term valuation reset driven by uncertainty, not a long-term impairment of demand.

Investors hate ambiguity more than bad news. And AI introduces ambiguity by changing how value is delivered, not whether value exists.

Cybersecurity spending isn’t discretionary. It’s not a “nice to have.” 

It’s closer to rent, electricity, and insurance. Companies don’t decide to “pause security” because the tech landscape got more dangerous. They spend more.

That’s especially true as:

• AI workloads concentrate valuable data
• Regulations tighten around data protection
• Nation-state cyber activity escalates
• Critical infrastructure becomes increasingly digital

None of these trends point to lower cybersecurity demand. Instead, they point to sustained, structural growth.


Why This Selloff Looks Like Opportunity

When great long-term businesses go on sale for short-term reasons, that’s when the math starts working in your favor.

Compressed valuations mean:

  • Lower expectations baked into prices
  • More upside if growth merely continues
  • Less downside if fear proves overblown

We’ve seen this pattern across multiple cycles…

A new technology scares investors. Stocks overshoot to the downside. Fundamentals quietly keep improving. Then the market wakes up.

Cybersecurity today feels a lot like cloud infrastructure stocks did during past “growth scares.” 

Same panic, same misunderstanding, same opportunity for investors willing to think past the next quarter.


What to Look for in Cybersecurity Winners

This isn’t about buying everything with “cyber” in the name. It’s about being selective.

The companies best positioned coming out of this reset tend to share a few traits:

• Deep integration of AI and machine learning into core products
• Large, diversified customer bases across enterprise and government
• Recurring revenue models with high switching costs
• Platforms that scale across cloud, endpoint, network, and identity

In other words, businesses that understand cybersecurity as a living system — not a static toolset.

Those are the firms turning today’s fear into tomorrow’s moat.


Fear Creates Discounts — Courage Creates Returns

I’ll leave you with this…

Every time markets panic over technological change, they assume replacement instead of reinforcement. 

But the biggest winners usually aren’t wiped out — they adapt, absorb the new tech, and emerge stronger.

AI doesn’t make cybersecurity irrelevant. It makes it indispensable.

The current selloff isn’t telling you the future is bleak. It’s telling you investors are scared. 

And fear, when divorced from fundamentals, is where opportunity lives.

This is one of those moments.

If you want to beat the market, you can’t think like the market. You have to be willing to step in when others are stepping away — to buy when headlines are loud and prices are quiet…

To be bold when others are fearful.

That’s not just a slogan. It’s how real outperformance is made.


5 Stocks Positioned for the Coming Global Arms Race

After two years of Russia, Iran and China lobbing hypersonic missiles around the globe and past missile defense systems, the Pentagon has finally decided it’s not playing around anymore.

In its most recent budget cycle, the U.S. Department of War requested roughly $13 billion for missile defense alone. That includes funding for space-based tracking layers, hypersonic intercept research, and next-generation radar systems. 

At the same time, the Space Development Agency is building out a proliferated low-Earth orbit network that’s expected to scale into the hundreds of satellites over successive tranches. Individual awards are being issued in batches of 18 to 28 spacecraft at a time — and they’re coming with price tags in the hundreds of millions to multi-billions of dollars.

Meanwhile, radar modernization programs are shifting from low-rate initial production toward full-rate manufacturing — a signal that deployment, not experimentation, is the goal.

Put it all together and the message is clear: this is a layered defense build-out spanning orbit, atmosphere, and ground.

For investors, there’s real opportunity to be found in the companies embedded inside the architecture — the ones building the space sensors, ground radar, propulsion systems, hypersonic weapons, and the test infrastructure that makes all of it possible.

Here are six companies well positioned to catch all that money coming down the pike. 


Large Cap: The Prime Contractors Owning the Architecture

Lockheed Martin (LMT)

The go-to defense stock is a go-to for a reason. 

Lockheed Martin generates more than $65 billion in annual revenue and remains one of the largest U.S. defense primes. 

In early February 2026, the company delivered the first Sentinel A4 radar from Low-Rate Initial Production Lot 2 to the U.S. Army and completed the first phase of Initial Operational Test and Evaluation. The Sentinel A4 program includes 19 systems in LRIP-2 alone, with additional procurement expected as the Army modernizes its air and missile defense network.

Sentinel A4 expands 3D radar coverage and improves detection of cruise missiles, drones, and aircraft in contested environments. While not a space asset, it is a critical ground-layer component in the same missile-defense architecture supported by space-based tracking.

The risk profile is moderate relative to smaller peers, but growth is steadier and backlog-driven.

L3Harris Technologies (LHX)

L3Harris, with annual revenue above $19 billion, has become a central player in missile-tracking satellites. 

The company has launched infrared missile-tracking spacecraft for both the Space Development Agency and the Missile Defense Agency, including systems tied to Hypersonic and Ballistic Tracking Space Sensor initiatives.

Management has emphasized delivering operational satellites to orbit in just over three years from program authorization. That timeline matters in a threat environment where adversaries are fielding maneuverable hypersonic systems.

The shift from prototype to production is key. L3Harris is now in full-scale production for multiple tracking-layer tranches, integrating advanced infrared payloads and processing algorithms capable of delivering fire-control-quality tracking data. 

That implies multi-year manufacturing and sustainment revenue rather than episodic development contracts.


Mid Cap: Focused Leverage to Space and Hypersonics

Rocket Lab (RKLB)

Rocket Lab has evolved from a small launch provider into a vertically integrated space systems contractor. 

The company has secured more than $1.3 billion in cumulative Space Development Agency awards, including an $816 million prime contract to build 18 missile-defense satellites for the Tracking Layer Tranche 3, following a prior $515 million award for 18 Transport Layer satellites.

Acting as a prime contractor on missile-tracking spacecraft moves Rocket Lab into higher-value segments of the national security supply chain. It is now designing, building, and integrating spacecraft rather than relying solely on launch cadence.

The company continues to develop its Neutron medium-lift rocket while scaling satellite production. 

Execution risk remains, but backlog tied to defense customers provides multi-year revenue visibility uncommon among smaller space companies.

Kratos Defense & Security Solutions (KTOS)

Kratos generates roughly $1 billion in annual revenue and operates across unmanned systems, propulsion, and hypersonic test infrastructure. 

In mid-February 2026, the company announced a new contract focused on streamlining hypersonic materials development, incorporating advanced modeling, simulation, and infrastructure investments such as Project Helios.

Materials are a bottleneck in hypersonic flight. Sustained Mach 5+ velocities generate extreme thermal and structural stress. Increasing test throughput and validation capacity accelerates the transition from laboratory prototype to operational system.

Kratos already participates in MACH-TB hypersonic test programs and produces propulsion systems for drones and missiles. Expanding into materials infrastructure deepens its integration in the hypersonic ecosystem. Revenue per program may be smaller than large primes, but growth rates can be more sensitive to incremental awards.


Small Cap: High-Volatility Optionality

Starfighters Space (FJET)

Starfighters Space is a micro-cap aerospace company operating the world’s largest commercial fleet of supersonic F-104 aircraft out of Kennedy Space Center. 

Its STARLAUNCH I concept is an air-launch system designed for sub-orbital payload deployment and hypersonic test applications. 

According to the recent company briefing document, STARLAUNCH I completed wind-tunnel testing evaluating clean separation from the F-104 platform at Mach 0.85 and Mach 1.3, with correlation to computational fluid dynamics models.

The company has stated it is progressing into Critical Design Review, a milestone intended to validate design maturity before building a demonstrator vehicle. 

It has also begun procuring instrumented drop-test articles to validate real-world separation dynamics .

From a market standpoint, the stock has recently experienced extreme volatility, including sharp drawdowns tied to leadership changes with moves of 50%+ in short windows and even an 80%+ rebound during a recent space-tech rally. 

The bull case is clear but high risk. 

If defense agencies increasingly demand rapid hypersonic and sub-orbital test cycles, a reusable supersonic air-launch platform could offer flexibility and cost advantages versus traditional ground launches. 


The Bottom Line: Positioning Across the Stack

With missile defense funding exceeding $13 billion annually, multi-hundred-satellite LEO tracking plans, and near-billion-dollar hypersonic weapon contracts, all signs point to a structural shift in defense procurement priorities. 

Production is underway. Satellites are on orbit. Radar systems are moving through operational testing.

Large caps offer scale and backlog durability. Mid-caps provide targeted leverage to space manufacturing and hypersonic infrastructure. Small caps like Starfighters Space (FJET) offer an aggressive risk/reward profile that some investors might find compelling.

Disclaimer: This is a paid marketing advertisement for informational purposes only and should not be construed as personalized investment advice. The Investment Journal is not a registered broker-dealer or investment advisor and is published on behalf of Creative Direct Marketing Group (“CDMG”), which has retained and compensated The Investment Journal for advertising and investor awareness services. CDMG may also be compensated by the featured company or other third parties, creating a material conflict of interest. Third parties, including company insiders or shareholders, as well as The Investment Journal and its affiliates, may buy or sell securities of the featured company at any time without notice, which may impact the market price. Information presented is believed to be reliable but is not guaranteed as to accuracy or completeness, and forward-looking statements involve risks and uncertainties. Investing in securities involves substantial risk, including the possible loss of principal. Conduct your own due diligence and consult a licensed financial professional before making any investment decision.

It’s not often a budget line item tells you where the world is headed.

But when the U.S. Department of Defense requests $66 billion in IT spending for fiscal 2026 — up $1.8 billion from the prior year — and places artificial intelligence at the top of the priority list across every service branch, it signals something bigger than an incremental upgrade cycle. It signals a strategic shift.

At the same time, industry forecasters are projecting the global AI in defense and aerospace market could expand from $4.2 billion to $42.8 billion by 2036—a tenfold increase powered by autonomous systems and real-time intelligence processing.

Against that backdrop, five companies operating at the intersection of aerospace, AI, and national security are drawing attention: Starfighters Space (NYSE American: FJET), Archer Aviation (NYSE: ACHR), AeroVironment (NASDAQ: AVAV), Redwire (NYSE: RDW), and V2X (NYSE: VVX).

The broader playing field is expanding too. The global space economy reached $626 billion in 2025 and is projected to surpass $1 trillion by 2034, with defense and sovereignty emerging as the dominant growth engines.

Meanwhile, NASA continues building the knowledge base needed for long-duration missions: ISS crew members are conducting real-time cardiovascular monitoring and psychological assessments aimed at preparing humans for deeper spaceflight.

In other words: the intelligence stack is rising, the operational demands are growing, and the aerospace layer is becoming more strategic by the quarter.

Starfighters Space (NYSE American: FJET): From wind tunnel validation to Critical Design Review

Starfighters Space recently announced it is moving forward to a Critical Design Review (CDR) for STARLAUNCH 1, with support from GE Aerospace. The purpose of the CDR is to confirm design maturity and support the program’s transition into its next phase of build and test planning.

In aerospace development, a CDR functions as a structured milestone—an integrated, detailed review of the system’s design—before a program proceeds to full-scale fabrication, integration, and formal test execution. In this case, the review will evaluate design documentation for the launch vehicle and its interfaces with the carrier aircraft, emphasizing configuration control, manufacturability, verification plans, and test readiness.

The CDR milestone builds on Starfighters’ recently completed subsonic and supersonic wind tunnel testing for STARLAUNCH 1. The testing demonstrated clean separation behavior at Mach 0.85 and Mach 1.3 across ten successful runs, with results showing strong agreement between computational fluid dynamics predictions and experimental data. The company has also initiated procurement of instrumented drop test articles to evaluate separation dynamics under actual flight conditions.

“We execute StarLaunch as a series of practical, documented steps to space,” said Tim Franta, Director and VP Development at Starfighters. “A critical design review is where we confirm that the design is ready for the next phase. Our team is dedicated and focused on the mission, and we are staying disciplined as we progress STARLAUNCH 1.”

GE Aerospace support and a supersonic test campaign from Kennedy Space Center

GE Aerospace has supported Starfighters’ StarLaunch development through prior engineering work and flight test activities, including a recent supersonic flight test campaign carrying an advanced propulsion test vehicle during three captive carry missions from Kennedy Space Center. That work supports GE Aerospace’s Atmospheric Test of Launched Air-breathing System (ATLAS) program, focused on advancing solid fuel ramjet propulsion technology, funded by the U.S. Department of Defense under Title III of the Defense Production Act.

STARLAUNCH 1 is being developed as a sub-orbital vehicle designed to support short-duration microgravity missions, serving as a pathfinder for future air-launched concepts. In parallel, Starfighters’ validated separation work supports its broader aerospace testing services, including programs requiring clean separation for advanced and hypersonic vehicle testing.

The company also states it operates the only commercial fleet in the free world capable of carrying underwing test payloads at speeds greater than Mach 2 (more than 1,500 mph)—positioning its F-104 platform as a high-performance testbed for both government and commercial partners.

Archer Aviation (NYSE: ACHR): NVIDIA compute, aviation AI, and “autonomy-ready” controls

Archer Aviation recently announced plans to develop and deploy next-generation AI technologies for aviation using the NVIDIA IGX Thor platform. At CES 2026 in Las Vegas, Archer unveiled three core development areas:

• Real-time sensor fusion for enhanced pilot situational awareness

• Predictive health monitoring for proactive aircraft system maintenance

• Autonomy-ready flight controls pairing IGX Thor computing architecture with Archer’s proprietary avionics and control software to support future autonomous and semi-autonomous operations

“CES has always been a launchpad for technologies that reshape industries, so we’re proud to announce our AI collaboration with NVIDIA here,” said Adam Goldstein, Founder and CEO of Archer Aviation. “NVIDIA’s AI compute capabilities and software stack give us the foundation to accelerate toward safer, smarter aircraft systems and modernize how aviation interfaces with the world’s airspace.”

The company is developing Midnight, a piloted electric vertical takeoff and landing aircraft intended for commercial urban air mobility. Archer holds FAA Part 135 air carrier certification and has secured commercial launch agreements with partners including United Airlines and Soracle, targeting initial commercial operations in select U.S. metro markets.

AeroVironment (NASDAQ: AVAV): AI-accelerated materials and biotech work under a $75M Air Force task order

AeroVironment recently received a $75 million task order from the U.S. Air Force to advance biotechnology and smart materials under the Functional Responsive Experimentation for Systems and Humans (FRESH) program at Wright Patterson Air Force Base in Dayton, Ohio. The period of performance is 60 months.

The effort involves developing and evaluating new materials, processing methods, and modeling techniques to create advanced polymers and responsive materials designed to enhance the performance and resilience of Air Force assets across air, space, and weapons systems, expanding the company’s ongoing work with the Air Force Research Laboratory.

“We’re entering an era where biology and materials science are converging,” said Dr. John Hogan, Vice President of Defense and Interagency Services at AeroVironment. “Our work under this program explores that frontier, creating responsive systems that enhance human performance, reduce maintenance burdens, and ensure operational dominance for the Air Force.”

The company’s research will leverage AI to speed discovery, testing, and environmental evaluation, with applications spanning cognitive and physiological monitoring, flexible electronics, additive smart materials, and synthetic biology. AeroVironment continues expanding its defense technology portfolio beyond its established Switchblade loitering munition and Puma unmanned aircraft platforms.

Redwire (NYSE: RDW): Positioning for homeland defense modernization under SHIELD

Redwire recently announced its selection for the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) contract—an indefinite-delivery/indefinite-quantity contract vehicle with a ceiling of $151 billion.

“Redwire’s proven space and defense technologies, including unmanned aerial systems, advanced sensors, maneuverable spacecraft platforms, and agent-based modeling and simulation, position us to deliver resilient, multi-domain solutions for national security missions,” said Peter Cannito, Chairman and CEO of Redwire. “We are excited to continue advancing capabilities that help protect the homeland and support mission partners across the Department of Defense.”

The company employs approximately 1,300 people across the United States and Europe, focused on aerospace infrastructure, autonomous systems, and multi-domain operations leveraging digital engineering and AI automation, with capabilities spanning unmanned platforms, advanced sensors, and maneuverable spacecraft for government and commercial partners.

V2X (NYSE: VVX): ATSP5 access and defense microelectronics modernization pathways

V2X recently secured a position on Advanced Technology Support Program 5 (ATSP5), a $25 billion multiple-award contract administered by the Defense Microelectronics Activity under the Office of the Secretary of Defense. The program scope includes engineering development from system studies and prototyping through testing, integration, and limited production—covering lifecycle technology support for embedded systems, network-centric warfare systems, and large-scale defense integrations.

“Winning a position on the ATSP5 enables V2X as a leader in transformative engineering solutions,” said Jeremy C. Wensinger, President and Chief Executive Officer of V2X. “Our selection places us at the forefront of defense modernization, allowing us to deliver advanced capabilities that don’t simply respond to threats and system obsolescence, but anticipate and evolve with them.”

The company brings decades of expertise in rapid acquisition, systems engineering, microelectronics supply assurance, and the application of advanced technologies including AI. The ATSP5 program creates pathways for modernization, overcoming obsolescence challenges, extending lifecycle of aging defense equipment, and advancing AI-optimized systems and large-scale AI orchestration capabilities to address emerging threats.

DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. The publisher is not licensed under securities laws to address individual financial situations. This is a digital media distribution and is neither an offer nor recommendation to buy or sell any security. Additional conflict-of-interest and risk disclosures apply.

When Jensen Huang, the CEO of NVIDIA, says something matters, I pay attention…

Not because he’s charismatic or because NVIDIA stock has become a market legend — but because he sits at the choke point of the AI economy. 

He sees what’s coming before almost anyone else.

And recently, Huang said the quiet part out loud: AI doesn’t scale without energy. 

Data centers can be built. Chips can be produced. Software can iterate at light speed. 

But if the electrons don’t show up on time — reliably, affordably, and in massive quantities — the whole AI boom hits a wall.

That single observation reframes everything…

This isn’t just an AI story anymore. It’s an infrastructure story. 

And not a small one…

What’s unfolding now looks eerily similar to the last time America realized it needed to rewire itself to stay competitive: the birth of the Interstate Highway System.

Back then, the challenge was physical mobility. Today, it’s digital intelligence. 

And just like the highways, whoever builds and controls the infrastructure underneath the transformation will quietly mint fortunes.

From Chips to Kilowatts: The Constraint Nobody Can Ignore

For the last two years, investors have obsessed over GPUs, models, and hyperscalers.

That made sense — at first…

But AI workloads are fundamentally different from anything that came before them. 

Training and inference at scale require constant, uninterrupted, energy-dense power. 

Not occasionally. Not theoretically. Every second of every day.

A single large AI data center can consume as much electricity as a mid-sized American city. 

Now multiply that by hundreds — soon thousands — of facilities.

This is why the conversation has shifted. Quietly at first. Now unmistakably.

AI isn’t compute-limited. It’s power-limited.

And the companies that solve that problem aren’t just supporting the AI boom — they’re defining how big it can get.

The New Interstate System Runs on Electrons

When President Eisenhower pushed the interstate highway vision in the 1950s, it wasn’t framed as an “infrastructure trade.” 

It was framed as national competitiveness, economic efficiency, and security. But those roads also unlocked decades of growth most people now take for granted.

AI infrastructure plays the same role today…

Data centers are the factories of the intelligence age. 

Power generation, transmission, and fuel supply are the highways that connect them. 

And just like the original buildout, this one will favor companies that already own hard assets, permitting expertise, and real-world operating experience.

This isn’t a science project. It’s heavy industry.

Natural Gas: The Backbone Nobody Wants to Admit Is Essential

For all the talk about futuristic energy solutions, the truth is simple: AI needs power now, not in ten years. 

That’s why natural gas has become the default solution for next-generation data centers.

Gas turbines are dispatchable. They’re scalable. They can be colocated directly next to data centers. 

And — critically — they can be connected straight into existing pipeline infrastructure.

This is why you’re seeing partnerships between data center developers and energy giants like EQT, Williams Companies, and Kinder Morgan. 

These firms don’t just produce gas. They move it, store it, and deliver it with industrial precision.

Some data centers are now being designed with dedicated gas hookups and on-site turbines, bypassing strained electrical grids entirely. 

That’s not a temporary workaround. It’s a structural shift.

In the AI age, energy independence isn’t just geopolitical. It’s computational.

Geothermal: Old Technology, Perfect Timing

If natural gas is the backbone, geothermal may become the sleeper hit…

Geothermal offers something AI desperately needs: constant, baseload power with minimal variability. 

No sun cycles. No wind forecasts. Just heat from the Earth, converted into electricity 24/7.

Companies like Ormat Technologies have been quietly operating geothermal plants for decades. 

And what’s changed isn’t just the technology — it’s the demand profile. AI data centers are uniquely suited to geothermal’s strengths.

Even oil and gas expertise is bleeding into this space, with drilling techniques originally developed for hydrocarbons now being repurposed to unlock deeper geothermal resources. 

This is where the optimistic futurist in me gets excited: legacy energy know-how powering next-generation intelligence.

The result? Cleaner power, long asset lives, and predictable output — exactly what hyperscale AI requires.

Hydropower: Where AI Meets Pure Physics

Hydropower doesn’t get headlines. It doesn’t trend on social media. 

But it works. And it always has.

And for energy-hungry data centers, it’s nearly perfect.

That’s why firms like Brookfield Renewable and NextEra Energy are suddenly far more relevant to the AI story than most investors realize. 

Their hydro assets generate steady, low-cost electricity at scale — exactly what advanced computing needs.

This isn’t about virtue signaling. It’s about physics and economics aligning.

Which brings us to one of the most fascinating examples in the entire space.

Bitzero: Building AI on Water, Not Words

One of the most compelling case studies in AI-powered infrastructure is Bitzero.

Bitzero is building data centers powered primarily by hydropower — clean, consistent, and abundant. 

Instead of fighting grid congestion or scrambling for gas supply, Bitzero situates its operations where energy is already flowing.

This model flips the script…

Rather than asking, “How do we get power to the data center?” Bitzero asks, “Where does the power already exist in excess — and how do we bring AI to it?”

That’s not just smart. It’s inevitable.

As AI workloads expand, data centers will increasingly migrate toward energy sources rather than forcing energy sources to migrate toward them. 

Bitzero is early — but it’s early in the right direction.

The Winners Won’t Look Like Traditional Tech Stocks

Here’s the part most investors still miss…

The biggest winners of the AI age won’t all look like software companies or chip designers. 

Some will look like utilities. Others will look like pipeline operators. A few will look like strange hybrids of energy producer and digital landlord.

Companies like Digital Realty are already repositioning themselves as energy infrastructure platforms as much as real estate plays. 

Hyperscalers like Microsoft are locking in long-term power agreements and even investing directly in generation capacity.

This is what a true platform shift looks like… 

It pulls in industries that once felt boring and makes them mission-critical overnight.

Why This Buildout Will Be Bigger Than Anyone Expects

The Interstate Highway System didn’t just enable transportation. It reshaped cities, commerce, defense, and culture. 

AI infrastructure will do the same.

Energy demand from AI won’t plateau quickly…

Models will get larger. Applications will multiply. Entire industries will become compute-native. 

And every step of that journey pulls more electrons through wires, pipes, turbines, dams, and wells.

That’s why this isn’t a trade. It’s a generational investment theme.

The optimistic futurist in me sees something profound here: a reindustrialization of America driven not by fear, but by ambition. By the desire to build intelligence at scale. 

And by the realization that the future still runs on very real, very physical infrastructure.

The Quiet Conclusion Most Investors Haven’t Reached Yet

AI is not just software eating the world.

It’s energy reshaping it.

Those who understand that now — before the headlines catch up — have a rare opportunity to position themselves on the right side of history. 

The companies supplying the power behind artificial intelligence won’t just benefit from the boom.

They’ll define how big it can become.

And that’s where some of the most enduring fortunes of the next decade will be built.